A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples